Answers are grounded in this paper and cite their sources.
Biologic (N = 531) Nonbiologic (N = 1306) No systemic treatment (N = 2520) pValue SMD Demographics Age 65.4 ± 8.2 65.8 ± 8.6 65.7 ± 8.9 0.702 0.030 Male 516.5 (97.3) 1278.0 (97.5) 2448.5 (97.3) 0.942 0.012 Race Black 43.8 (8.2) 122.3 (9.3) 193.1 (7.7) 0.201 0.042 White 68.7 (12.9) 169.0 (12.9) 293.8 (11.7) 0.494 0.037 Other 14.0 (2.6) 34.3 (2.6) 65.0 (2.6) 0.997 0.007 Body mass index 31.8 ± 6.2 31.7 ± 6.4 31.7 ± 6.4 0.876 0.018 Comorbidities Cerebrovascular disease 78.5 (14.8) 200.3 (15.3) 387.7 (15.4) 0.941 0.010 Chronic kidney disease 106.8 (20.1) 267.9 (20.4) 503.9 (20.0) 0.959 0.004 Congestive heart failure 149.1 (28.1) 373.3 (28.5) 704.1 (28.0) 0.953 0.001 Diabetes 280.0 (52.7) 669.0 (51.0) 1286.4 (51.1) 0.791 0.022 Hypertension 475.2 (89.5) 1171.1 (89.3) 2246.2 (89.3) 0.989 0.008 Hyperlipidaemia 469.1 (88.3) 1157.2 (88.3) 2229.1 (88.6) 0.954 0.009 Prior myocardial infarction 162.1 (30.5) 391.2 (29.8) 752.6 (29.9) 0.958 0.013 Peripheral arterial disease 102.7 (19.3) 257.0 (19.6) 488.9 (19.4) 0.989 0.002 Tobacco use 339.4 (63.9) 846.0 (64.5) 1626.6 (64.7) 0.954 0.009 Coronary angiography Findings No CAD 71.3 (13.4) 167.1 (12.7) 322.5 (12.8) 0.919 0.020 Nonobstructive CAD 136.2 (25.6) 335.7 (25.6) 634.6 (25.2) 0.958 0.009 Obstructive CAD 323.5 (60.9) 808.3 (61.7) 1559.0 (62.0) 0.906 0.023 Medical therapy after coronary angiography Statin 399.0 (75.1) 992.2 (75.7) 1903.9 (75.7) 0.967 0.008 Beta blocker 395.0 (74.4) 987.9 (75.4) 1904.4 (75.7) 0.827 0.015 ACEi or ARB 251.1 (47.3) 637.0 (48.6) 1220.3 (48.5) 0.873 0.016
No takes yet. Share an insight, caveat, or question.
Salahuddin et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: